NasdaqGS - Nasdaq Real Time Price • USD
iRhythm Technologies, Inc. (IRTC)
As of 2:08 PM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 8 | 8 |
| Avg. Estimate | -0.98 | -0.77 | -2.91 | -1.71 |
| Low Estimate | -1.31 | -1.1 | -4.11 | -3.06 |
| High Estimate | -0.7 | -0.56 | -2.07 | -0.86 |
| Year Ago EPS | -1.29 | -0.61 | -4.04 | -2.91 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 12 | 12 |
| Avg. Estimate | 128.41M | 146.48M | 580.81M | 688.07M |
| Low Estimate | 127M | 144.1M | 578.3M | 680.7M |
| High Estimate | 131.54M | 148.77M | 583.81M | 698.97M |
| Year Ago Sales | 107.05M | 124.13M | 492.68M | 580.81M |
| Sales Growth (year/est) | 20.00% | 18.00% | 17.90% | 18.50% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.9 | -0.78 | -0.66 | -0.6 |
| EPS Actual | -1.29 | -0.61 | -0.89 | -1.26 |
| Difference | -0.39 | 0.17 | -0.23 | -0.66 |
| Surprise % | -43.30% | 21.80% | -34.80% | -110.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.98 | -0.77 | -2.91 | -1.71 |
| 7 Days Ago | -0.99 | -0.78 | -2.96 | -1.74 |
| 30 Days Ago | -0.99 | -0.78 | -2.96 | -1.74 |
| 60 Days Ago | -0.72 | -0.56 | -2.29 | -1.27 |
| 90 Days Ago | -0.72 | -0.56 | -2.29 | -1.27 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 1 | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | IRTC | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 24.00% | -- | -- | 0.80% |
| Next Qtr. | -26.20% | -- | -- | 9.60% |
| Current Year | 28.00% | -- | -- | 4.50% |
| Next Year | 41.20% | -- | -- | 13.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Maintains | JP Morgan: Overweight to Overweight | 2/23/2024 |
| Maintains | Canaccord Genuity: Buy to Buy | 2/23/2024 |
| Maintains | Needham: Buy to Buy | 2/23/2024 |
| Maintains | Needham: Buy to Buy | 1/8/2024 |
| Maintains | Truist Securities: Buy to Buy | 12/22/2023 |
| Maintains | Truist Securities: Buy to Buy | 12/12/2023 |
Related Tickers
LIVN LivaNova PLC
52.22
-1.02%
KIDS OrthoPediatrics Corp.
30.17
+2.41%
OFIX Orthofix Medical Inc.
13.02
-0.04%
LUNG Pulmonx Corporation
7.39
-1.47%
PEN Penumbra, Inc.
201.42
-0.21%
NARI Inari Medical, Inc.
38.59
-0.13%
QDEL QuidelOrtho Corporation
39.02
+1.99%
CNMD CONMED Corporation
72.26
+1.65%
IRMD IRADIMED CORPORATION
41.41
+2.61%
INGN Inogen, Inc.
6.84
-3.53%